Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.
Product Name: 3,3-Dichloro-1-(4-nitrophenyl)-2-piperidinone
CAS Number: 881386-01-2
Molecular Weight:  289.1176
Molecular Formula:  C11H10Cl2N2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.